GHP Investment Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.5K | Hold |
1,500
| – | – | ﹤0.01% | 458 |
|
|
2025
Q1 | $106K | Hold |
1,500
| – | – | 0.01% | 418 |
|
|
2024
Q4 | $98.6K | Hold |
1,500
| – | – | ﹤0.01% | 428 |
|
|
2024
Q3 | $105K | Hold |
1,500
| – | – | ﹤0.01% | 430 |
|
|
2024
Q2 | $123K | Hold |
1,500
| – | – | 0.01% | 415 |
|
|
2024
Q1 | $131K | Hold |
1,500
| – | – | 0.01% | 415 |
|
|
2023
Q4 | $145K | Hold |
1,500
| – | – | 0.01% | 400 |
|
|
2023
Q3 | $130K | Hold |
1,500
| – | – | 0.01% | 406 |
|
|
2023
Q2 | $134K | Hold |
1,500
| – | – | 0.01% | 403 |
|
|
2023
Q1 | $146K | Hold |
1,500
| – | – | 0.01% | 397 |
|
|
2022
Q4 | $155K | Hold |
1,500
| – | – | 0.01% | 388 |
|
|
2022
Q3 | $127K | Hold |
1,500
| – | – | 0.01% | 394 |
|
|
2022
Q2 | $124K | Sell |
1,500
-468
| -24% | -$38.7K | 0.01% | 398 |
|
|
2022
Q1 | $152K | Buy |
+1,968
| New | +$152K | 0.01% | 387 |
|
|
2015
Q3 | – | Sell |
-1,500
| Closed | -$217K | – | 276 |
|
|
2015
Q2 | $217K | Buy |
+1,500
| New | +$217K | 0.05% | 264 |
|